Ginkgo Biloba Dose Guidelines: 120 mg vs 240 mg

Most clinical trials of ginkgo biloba have used daily doses between 120 mg and 240 mg of a standardized leaf extract, and the weight of evidence favors 240 mg per day for the conditions where ginkgo shows the strongest results. That said, “240 mg of ginkgo” is a deceptively simple recommendation, because the formulation, the specific extract, the condition being treated, and even how the dose is split across the day all shape what a person actually absorbs and whether it helps.

The Standard Dose Range

When researchers and clinicians talk about ginkgo biloba dosing, they almost always mean a concentrated, standardized extract rather than raw leaf powder. The most extensively studied version, known as EGb 761, is adjusted to contain roughly 22–27% flavonoid glycosides and 5–7% terpene lactones, with ginkgolic acids held below 5 parts per million.¹ These numbers matter because unstandardized products can vary enormously in how much of the active compounds they deliver.

Traditional dosing advice for standardized ginkgo extract calls for 40 to 60 mg taken three to four times a day, adding up to 120–240 mg daily, with at least four to six weeks of consistent use before expecting noticeable effects.² More recent clinical guidelines, especially for dementia, have increasingly settled on 240 mg per day as the recommended target, with one German analysis concluding that 120 mg per day may not reliably produce a response.³

Why 240 mg Per Day Outperforms 120 mg for Cognition

The best evidence on ginkgo and cognitive decline comes from trials in people already experiencing memory problems or diagnosed with dementia. A systematic review and meta-analysis of placebo-controlled trials found that a daily dose of 240 mg EGb 761 was needed to reach effects that were clinically meaningful, not just statistically significant.⁴ Another meta-analysis confirmed that 240 mg per day improved not only cognitive function but also daily living activities and behavioral symptoms, with stronger results than what the pooled data showed at lower doses.⁵

A recent evidence-based review of dosing guidelines across the literature found that while studies have tested doses ranging from 120 to 450 mg per day, the consistent finding is that doses at or above 240 mg per day are linked to improved cognitive outcomes in people who already have symptoms.⁶ Below that threshold, results become unreliable. This doesn’t mean 120 mg does nothing, but the effect is smaller and less consistent across trials.

Dosing for Conditions Beyond Dementia

Ginkgo has been studied for a surprisingly wide range of health problems, and the dose that seems to work varies depending on what you’re trying to treat.

Tinnitus

For tinnitus, a systematic review of eight randomized, placebo-controlled trials using EGb 761 found that the extract consistently outperformed placebo in reducing tinnitus volume and overall severity.⁷ Most of these trials used 120 to 240 mg per day. The evidence is positive here, though it applies specifically to this one standardized extract, not to ginkgo supplements broadly.

Peripheral Artery Disease

People with peripheral artery disease, especially those who get leg pain while walking, have been a target of ginkgo research for decades. A head-to-head trial comparing 120 mg and 240 mg daily found that the higher dose produced a substantially larger improvement in pain-free walking distance: roughly 107 meters gained versus about 61 meters with the lower dose.⁸ However, a Cochrane review pooling data from multiple trials found that the overall benefit translated to an increase of only about 65 meters on a flat treadmill and noted that publication bias probably inflated even that modest number.⁹ A separate randomized trial at 300 mg per day failed to reach statistical significance for either maximal or pain-free walking time.¹⁰ The evidence for peripheral artery disease is weaker than for cognition, and the practical benefit, even at higher doses, is modest enough that it shouldn’t replace exercise therapy or other established treatments.

Anxiety

One well-designed trial tested ginkgo for generalized anxiety disorder at two doses: 240 mg and 480 mg daily. Both doses beat placebo, but there was a clear dose-response relationship, with the 480 mg group showing the largest drop in anxiety scores.¹¹ This is one of the few areas where doses above 240 mg have been formally tested and shown a proportionally larger effect. Still, this is only a single trial, so anyone considering ginkgo for anxiety should treat it as preliminary.

Single-Dose Effects in Healthy People

If you’re healthy and curious about ginkgo for a cognitive edge rather than treating a diagnosed condition, the picture is murkier and somewhat counterintuitive. A dose-response study in healthy young adults found that 240 mg and 360 mg improved the speed of attention in a dose-dependent way, with the effect appearing within a few hours and lasting at least six hours.¹² A different study confirmed this pattern but added an odd wrinkle: a standard 120 mg dose modestly improved memory quality, yet it actually slowed attention task performance, the opposite of what the higher-dose studies found.¹³

One study tested a single acute dose in healthy young volunteers and found improved sustained attention and pattern recognition after one dose, but when the same group took ginkgo daily for six weeks, the cognitive benefits vanished.¹⁴ This is a genuinely puzzling result and suggests that in young, healthy brains, the acute neurochemical effects of ginkgo may not translate into lasting cognitive enhancement with regular use. The evidence for ginkgo as a nootropic in healthy adults is thin and inconsistent compared to its evidence in people with existing cognitive decline.

Combination Products and Ginseng

Some supplements combine ginkgo with Panax ginseng, and a couple of trials suggest this pairing may be more effective than either herb alone for memory. A 14-week trial in healthy middle-aged adults found that a combination of 60 mg ginkgo and 100 mg ginseng per capsule, taken as either 160 mg twice daily or 320 mg once daily, improved an overall memory quality index by an average of about 7.5% over placebo.¹⁵ A separate acute-dose study in young volunteers found that 320 mg of the combination produced a significant and sustained improvement in demanding mental arithmetic tasks.¹⁶ The doses in these studies are notably lower than the 240 mg of ginkgo alone that dominates the dementia research, so it’s difficult to compare them directly. The combination data are interesting but limited to a small number of trials.

Formulation Matters More Than You’d Think

One of the most underappreciated aspects of ginkgo dosing is that two products labeled with the same milligram amount can deliver wildly different amounts of active compounds into your bloodstream. A pharmacokinetic study comparing three different ginkgo preparations found that peak blood levels of the key terpene lactones varied by roughly seven-fold between the lowest-performing product (a tincture) and EGb 761 tablets, even when the labeled daily dose was the same.¹⁷

This isn’t just a matter of extract quality. Even among tablet products containing the same extract, differences in how the tablet is manufactured, compressed, and coated can dramatically slow dissolution and reduce absorption. One study found that two products, both containing 120 mg of ginkgo extract, failed to show bioequivalence because the test product dissolved too slowly in the gut.¹⁸ The practical takeaway is that choosing a well-characterized extract with clinical trial backing, like EGb 761, provides much more confidence in dosing than choosing a generic “ginkgo biloba 120 mg” capsule from a random brand.

Drug Interactions at Standard Doses

One common concern is that ginkgo might thin the blood and interact dangerously with anticoagulants. The mechanism usually cited involves ginkgolides blocking platelet-activating factor, but lab work has shown that the concentrations needed to actually inhibit platelet aggregation are more than 100 times higher than the peak blood levels reached after taking 120–240 mg of EGb 761 orally.¹⁹ That doesn’t mean bleeding events with ginkgo never happen, but it suggests the platelet-related mechanism is probably not the culprit at normal doses.

As for liver enzyme interactions, EGb 761 was tested in healthy volunteers using a drug cocktail that probes the five major drug-metabolizing enzyme families. At 240 mg daily, the extract showed no meaningful inhibition or induction of CYP1A2, CYP2C9, CYP2C19, CYP2D6, or CYP3A4.²⁰ A separate study confirmed that standard ginkgo doses did not meaningfully alter the metabolism of drugs cleared through CYP2D6 or CYP3A4 pathways.²¹ However, lab studies on isolated liver cells have shown that ginkgo extract and bilobalide can induce CYP3A activity in a dose-dependent way at high concentrations.²² The in-lab effect hasn’t translated clearly into a clinical problem at recommended doses, but it’s a reason to be cautious about taking ginkgo alongside drugs with narrow therapeutic windows, especially at doses above 240 mg.

The Rodent Carcinogenicity Data

In 2013, the U.S. National Toxicology Program published a two-year gavage study in which rats and mice received ginkgo biloba extract at doses far above what humans take. The results were sobering: mice developed liver tumors, including hepatocellular carcinoma and hepatoblastoma, at all tested doses, and rats showed increased thyroid tumors.²³ The International Agency for Research on Cancer subsequently classified ginkgo biloba leaf extract as a possible human carcinogen (Group 2B).²⁴

Context matters here. The rodent doses ranged up to 2,000 mg per kilogram of body weight per day, which is orders of magnitude beyond human supplementation. And the extract used in the NTP study was not identical to EGb 761 in terms of purity or ginkgolic acid content. Still, the classification isn’t something to dismiss entirely, especially for people considering long-term, high-dose use. Human clinical trials lasting six months to a year have not flagged cancer signals, but those timeframes are short relative to the kind of exposure the rodent studies modeled.

Ginkgotoxin and Seizure Risk

Ginkgo leaves naturally contain a compound called ginkgotoxin (4′-O-methylpyridoxine), which interferes with vitamin B6 metabolism and can, at high enough exposure, provoke seizures. Well-manufactured standardized extracts are processed to minimize ginkgotoxin, but the concern isn’t zero.²⁵ Animal research has demonstrated that ginkgotoxin exposure causes dose-dependent seizure-like behavior, and that this effect is driven specifically by disrupting the pathway that produces the brain’s main inhibitory neurotransmitter.²⁶ For most people taking a quality extract at standard doses, the ginkgotoxin content is too low to be a practical risk. But for anyone with a seizure disorder, or anyone consuming crude leaf preparations or ginkgo seeds (which contain much higher ginkgotoxin levels), this is a real hazard to be aware of.

Ginkgo Dosing in Children

A handful of studies have explored ginkgo for attention-deficit/hyperactivity disorder in children. In an open-label trial, children were started at 80 mg per day and gradually increased to a maximum of 240 mg daily based on whether symptoms improved. At the maximum dose, the researchers observed possible improvements in ADHD symptoms and quality of life, with only mild side effects.²⁷ Another trial found that ginkgo combined with methylphenidate (the standard ADHD medication) reduced inattention scores more than methylphenidate alone. However, when ginkgo at 80–120 mg daily was tested head-to-head against methylphenidate, the herb was clearly less effective.²⁸ The evidence is too preliminary to recommend ginkgo as an ADHD treatment, but the trials suggest that doses up to 240 mg per day were tolerated in children without serious adverse events.

Why Raw Ginkgo Leaves Are Not a Shortcut

Some people assume they can skip the extract and brew ginkgo leaves into tea. The problem is that raw leaves vary enormously in active compound content depending on the individual tree, the time of year, and even leaf color. One analysis of three Dutch ginkgo trees found that ginkgolide B concentrations at peak season differed by nearly 70-fold between trees.²⁹ Concentrations are lowest in spring, peak in late summer or early autumn, and then decline before leaf fall. Even within the same harvest, leaf color signals different phytochemical profiles: yellow autumn leaves actually contain more total flavonoids than green summer leaves.³⁰

Beyond inconsistency, raw leaves come with much higher levels of ginkgolic acids, which are allergenic and potentially toxic. The industrial extraction process specifically targets these compounds for removal, and advanced processing methods can reduce ginkgolic acid content by over 80% compared to simple water extraction.³¹ Brewing leaves at home provides no control over dose, no removal of toxic constituents, and no way to know whether you’re getting enough of the terpene lactones that drive most of ginkgo’s studied effects. The clinical evidence applies to standardized extracts, and trying to approximate that with loose leaves is effectively guessing.

How the Dose Gets Into Your System

After you swallow a ginkgo tablet, the key terpene lactones reach peak blood levels fairly quickly, generally within one to two hours. But they also clear fast: half-lives for ginkgolide A, ginkgolide B, and bilobalide are all roughly two hours.³² This short half-life explains why the traditional dosing advice splits the daily amount into two or three doses spread across the day, rather than taking it all at once. Some clinical trials have tested once-daily dosing and still found effects, so the exact schedule isn’t as critical as hitting the total daily milligram target, but divided dosing keeps blood levels more stable.

Importantly, the pharmacokinetics are dose-linear at the ranges studied, meaning that doubling the dose roughly doubles the peak blood levels and overall exposure. There’s no saturation point at clinical doses where extra milligrams stop being absorbed. This linearity, combined with the short half-life, is part of why 240 mg per day consistently outperforms 120 mg: the body processes ginkgo quickly, and higher daily totals simply keep more of the active compounds available for longer.